within Pharmacolibrary.Drugs.ATC.S;

model S01EE06
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.01,
    Cl             = 0.01 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 0.001 / 1000000,
    adminCount     = 1,
    Vd             = 0.0001,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Latanoprostene bunod is a prostaglandin F2α analog indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. It is an ophthalmic solution approved for use in adults. The drug is hydrolyzed in the eye to produce two active moieties: latanoprost acid and nitric oxide, both contributing to IOP reduction.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters are not reported in peer-reviewed publications for latanoprostene bunod in humans. Based on estimated model for topically administered ophthalmic prostaglandin analogs.</p><h4>References</h4><ol><li><p>Cavet, ME, &amp; DeCory, HH (2018). The Role of Nitric Oxide in the Intraocular Pressure Lowering Efficacy of Latanoprostene Bunod: Review of Nonclinical Studies. <i>Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics</i> 34(1-2) 52–60. DOI:<a href=&quot;https://doi.org/10.1089/jop.2016.0188&quot;>10.1089/jop.2016.0188</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/28783422/&quot;>https://pubmed.ncbi.nlm.nih.gov/28783422</a></p></li><li><p>Krauss, AH, et al., &amp; Ongini, E (2011). Ocular hypotensive activity of BOL-303259-X, a nitric oxide donating prostaglandin F2α agonist, in preclinical models. <i>Experimental eye research</i> 93(3) 250–255. DOI:<a href=&quot;https://doi.org/10.1016/j.exer.2011.03.001&quot;>10.1016/j.exer.2011.03.001</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/21396362/&quot;>https://pubmed.ncbi.nlm.nih.gov/21396362</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end S01EE06;
